15/05/2026
One of the world’s most common hormone-related disorders affecting women is undergoing a major terminology shift as experts push for a name they believe better reflects the condition’s true complexity. Polycystic o***y syndrome, widely known as PCOS, is increasingly being referred to by some researchers as PMOS, short for metabolic reproductive syndrome.
Specialists argue that the older name placed too much emphasis on ovarian cysts, even though many patients diagnosed with the condition do not actually develop cysts. At the same time, the disorder affects far more than reproductive organs alone.
Researchers say the condition is deeply connected to hormones, metabolism, insulin regulation, fertility, inflammation, menstrual cycles, skin health, and body weight. Many women experience symptoms such as irregular periods, acne, excess facial hair growth, fatigue, insulin resistance, and difficulty becoming pregnant.
Experts behind the terminology change believe the newer name better represents the condition’s strong metabolic component, particularly its connection to insulin sensitivity and chronic inflammation. These underlying issues may also increase long-term risks for conditions such as type 2 diabetes and cardiovascular disease.
Supporters of the updated terminology hope it will reduce confusion among patients who were previously told they could not have PCOS because ovarian cysts were absent. Researchers also believe the change may encourage healthcare providers to approach the disorder as a whole-body metabolic and hormonal condition rather than viewing it only as a reproductive issue.
